PhaseBio Pharmaceuticals Inc (PHASQ): When they aim to preserve the NOLs, they...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Monday, 01/09/2023 2:59:46 PM

Monday, January 09, 2023 2:59:46 PM

When they aim to preserve the NOLs, they can only do it if the 'old and cold' equity survives. That looks good for existing shareholders.

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 08:42:06 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:32:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 08:28:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:55:08 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:17:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:17:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 12:52:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 04:34:57 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/25/2023 04:31:30 PM

InvestorsHub NewsWire

Only $200 per official company press release!